Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Hum Pathol. 2013 Nov 27;45(2):259–267. doi: 10.1016/j.humpath.2013.05.029

Table 4.

NY-ESO-1 expression in malignant melanoma lesions according to morphology

Morphology NY-ESO-1 expression
Primary (%) Metastatic (%) Total (%)
Melanoma
 Epithelioid 13 (65.0) 172 (83.5) 185 (83.3)
  With anaplastic features 1 (50) 5 (2.4)
 Spindle 1 (20.0) 22 (10.7) 23 (10.4)
  With desmoplastic features 0 3 (1.5)
 Mixed 1 (6.25) 8 (3.9) 9 (4.1)
 Balloon 1 (6.25) 4 (1.9) 5 (2.3)
 Total 16 206 222
Metastatic melanoma Positive (%) Negative (%) Total (%)
 Epithelioid 56 (32.6) 116 (67.4) 172
  With anaplastic features 2 (1.1) 3
 Spindle 2 (9.1) 20 (90.9) 22
  With desmoplastic features 2 (9.1) 1
 Mixed 0 8 (100) 8
 Balloon 0 4 (100) 4
 Total 58 148 206
Metastatic melanoma excluding multiple specimens from same patient
 Epithelioid 37 (30.8) 83 (69.2) 120
  With anaplastic features 2 (1.7) 3
 Spindle 2 (10.5) 17 (89.5) 19
  With desmoplastic features 2 (10.5) 1
 Mixed 0 7 (100) 7
 Balloon 0 2 (100) 2
 Total 39 109 148

NOTE. Mixed is epithelioid and spindle cell subtypes.